John Hillebrecht > DLA Piper LLP (US) > New York, United States > Lawyer Profile

DLA Piper LLP (US)
1251 6TH AVE,
NEW YORK, NY 10020-1104
NEW YORK
United States

Work Department

White Collar and Corporate Crime; Litigation, Arbitration and Investigations

Position

Partner; US National Co-Chair of the White Collar Crime, Investigations, and Government Enforcement Group

Lawyer Rankings

United States > Dispute resolution > Corporate investigations and white-collar criminal defense

Dealing with all facets of white-collar and regulatory enforcement cases, DLA Piper LLP (US) draws on its ability to supplement its domestic expertise with a vast global network to assist major corporations and individuals in extensive global investigations and enforcement proceedings. Particular areas of note for the practice are False Claims Act matters as well as incidents surrounding cybersecurity. A quartet of attorneys sits at the helm of the team, consisting of Karl Buch and John Hillebrecht in New York, as well as Chicago’s Jonathan King, and Courtney Saleski, who splits her time between Philadelphia and Washington DC. 2022 saw the arrival of a number of new partners to the practice, including former Vinson & Elkins LLP partners Matthew Jacobs and Jessica Heim in San Francisco. Further additions are Boston’s Eric Forni and Michelle Morgan in Wilmington, who held previous positions with the SEC and DOJ, respectively.

United States > Dispute resolution > Securities litigation: defense

DLA Piper LLP (US) has a diverse national corporate and securities litigation practice that spans the US, with offices in New York, California, Texas, Delaware and other key jurisdictions. It is particularly active in cases involving the life sciences, financial services, insurance, and technology sectors, hence a client base that includes Goldman Sachs, Abengoa and AxoGen, Inc. John Clarke in New York and Melanie Walker in Los Angeles are co-chairs of the practice. Clarke is representing Bristol-Myers Squibb Company in an action alleging breaches of a contingent value rights agreement. Caryn Schechtman in New York led the defense of AxoGen, which creates innovative nerve repair products, and achieved the dismissal of claims arising from its IPO. John Hillebrecht in New York and Jason Lewis in Dallas also play key roles in the practice. Experienced LA-based practitioner Richard Zelichov joined the firm from Katten in July 2023.